Table 3. Locations of bone metastases on CE-FDG-PET-CT vs CE-FDG-PET-MR.

	CE-FDG-PET-CT	CE-FDG-PET-MR
Appendicular skeleton	2/90 (2.22%)	8/141 (5.67%)
Vertebrae	29/90 (32.22%)	38/141 (26.95%)
Pelvic bones	35/90 (38.89%)	60/141 (42.55%)
Ribs	6/90 (6.67%)	9/141 (6.38%)
Sternum	12/90 (13.33%)	18/141 (12.76%)
Skull	6/90 (6.67%)	8/141 (5.67%)

Abbreviations: CE-FDG-PET-CT=contrast enhanced-fluorodexossyglucose-positron emission tomography-computed tomography; MR=magnetic resonance.

No statistically significant differences were found between locations of bone metastases on CE-FDG-PET-CT vs CE-FDG-PET-MR. Most of the bone metastases affected the spine and pelvic bones.